These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2113400)
21. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Holt RI; Simpson HL; Sönksen PH Diabet Med; 2003 Jan; 20(1):3-15. PubMed ID: 12519314 [TBL] [Abstract][Full Text] [Related]
22. Elevation of serum IGF-1 rather than sex steroids precedes proliferative diabetic retinopathy in Mauriac's syndrome. Chantelau E; Seppel T; Althaus C; Schönau E Horm Res; 1997; 48(3):131-4. PubMed ID: 11546930 [TBL] [Abstract][Full Text] [Related]
23. The role of growth hormone in diabetes mellitus. Holly JM; Amiel SA; Sandhu RR; Rees LH; Wass JA J Endocrinol; 1988 Sep; 118(3):353-64. PubMed ID: 3053958 [TBL] [Abstract][Full Text] [Related]
24. The effect of gonadotropin-releasing hormone agonists on growth hormone secretion in adult premenopausal women. Word RA; Odom MJ; Byrd W; Carr BR Fertil Steril; 1990 Jul; 54(1):73-8. PubMed ID: 2113490 [TBL] [Abstract][Full Text] [Related]
25. The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes. Bek T; Kjaergaard J Eur J Ophthalmol; 2004; 14(6):538-42. PubMed ID: 15638104 [TBL] [Abstract][Full Text] [Related]
26. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats. Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532 [TBL] [Abstract][Full Text] [Related]
27. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback. Ismail IS; Scanlon MF; Peters JR Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648 [TBL] [Abstract][Full Text] [Related]
28. Quantitation of retinal ablation in proliferative diabetic retinopathy. Reddy VM; Zamora RL; Olk RJ Am J Ophthalmol; 1995 Jun; 119(6):760-6. PubMed ID: 7785691 [TBL] [Abstract][Full Text] [Related]
29. Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Harel Z; Tannenbaum GS Pediatr Res; 1995 Nov; 38(5):747-53. PubMed ID: 8552444 [TBL] [Abstract][Full Text] [Related]
30. Anatomically specific changes in the expression of somatostatin, growth hormone-releasing hormone and growth hormone receptor mRNA in diabetic rats. Busiguina S; Argente J; García-Segura LM; Chowen JA J Neuroendocrinol; 2000 Jan; 12(1):29-39. PubMed ID: 10692141 [TBL] [Abstract][Full Text] [Related]
31. [Role of insulin-like growth factor I in the development of diabetic retinopathy]. Gacka M; Adamiec J Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339 [TBL] [Abstract][Full Text] [Related]
32. Surgical castration but not immuncastration is associated with reduced hypothalamic GnIH and GHRH/GH/IGF-I axis function in male rats. Han X; Li J; Cao X; Du X; Meng F; Zeng X Theriogenology; 2016 Jul; 86(2):657-65. PubMed ID: 27020878 [TBL] [Abstract][Full Text] [Related]
34. Effects of coadministered growth hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats. Bercu BB; Yang SW; Masuda R; Hu CS; Walker RF Endocrinology; 1992 Dec; 131(6):2800-4. PubMed ID: 1446617 [TBL] [Abstract][Full Text] [Related]
35. Secretion of growth hormone (GH)-releasing hormone by GH-producing pituitary adenoma assessed by cell immunoblot analysis. Kawamoto K; Uozumi T; Arita K; Takechi A; Kawamoto H Endocr J; 1995 Feb; 42(1):89-93. PubMed ID: 7599704 [TBL] [Abstract][Full Text] [Related]
36. Serous retinal detachment after panretinal photocoagulation for proliferative diabetic retinopathy: a case report. Schatz P; Aldayel A; Taskintuna I; Abdelkader E; Mura M J Med Case Rep; 2017 Sep; 11(1):265. PubMed ID: 28923115 [TBL] [Abstract][Full Text] [Related]
37. Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus. Clayton KL; Holly JM; Carlsson LM; Jones J; Cheetham TD; Taylor AM; Dunger DB Clin Endocrinol (Oxf); 1994 Oct; 41(4):517-24. PubMed ID: 7955462 [TBL] [Abstract][Full Text] [Related]
38. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Pfeiffer A; Spranger J; Meyer-Schwickerath R; Schatz H Diabetes; 1997 Sep; 46 Suppl 2():S26-30. PubMed ID: 9285495 [TBL] [Abstract][Full Text] [Related]
39. Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation. Wright AD; Kohner EM; Oakley NW; Hartog M; Joplin GF; Fraser TR Br Med J; 1969 May; 2(5653):346-8. PubMed ID: 5768460 [TBL] [Abstract][Full Text] [Related]
40. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Wilkinson-Berka JL; Wraight C; Werther G Curr Med Chem; 2006; 13(27):3307-17. PubMed ID: 17168853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]